Trending Articles
You may also like
Research & Development
The Berlin-based subsidiary will use the grant to advance the KlicMic R&D programme, creating targeted microcystin payloads for ADCs that aim to improve cancer therapy efficacy...
Simris Biologics secures €200K funding to develop microcystin-based payloads for antibody-drug conjugates
Read more
Research & Development
The company cited underinvestment in life sciences and the undervaluation of innovative medicines for the decision, raising questions about the UK’s competitiveness in...